Pulmatrix (PULM)
This biopharma’s stock was added to the Russell Microcap Index last month, and its shares are gathering momentum.
Pulmatrix (PULM) From The Konlin Letter
More than 30 million Americans and 30 million Europeans have a rare disease. Pulmatrix (PULM) is a clinical stage biopharmaceutical company innovative,...
Read More